Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

8 novembre 2018

09:03
IM HealthScience®, innovators of patented nonprescription medical foods, revealed results of a nationwide survey conducted among gastroenterologists who, by an overwhelming margin and for the fourth consecutive year, endorsed IBgard® as "the #1...

09:01
MMS Holdings Inc. (MMS) ? an award-winning, data-focused CRO ? announced that the company has successfully assisted Korea-based Vivozon Inc. in achieving a Fast Track Designation from the Food and Drug Administration (FDA) for VVZ-149, a non-opioid...

08:42
Houston-based biotechnology company Celltex Therapeutics Corporation announces that Gavin Publishers has published "Infusion of Autologous, Culture-Expanded, Adipose-derived Mesenchymal Stem Cells in the Treatment of Coexisting Autoimmune Disease."...

08:41
Two recent studies find advances in radiation therapy are helping to prolong or improve the lives of people with anal cancer, including those whose cancer has advanced to stage IV. Both studies were published in the International Journal of Radiation...

08:00
Financialnewsmedia.com News Commentary  The biotech space is thriving in the midst of rising competition as it relates to the development of innovative cancer treatments. Leaders in the industry are spending millions on research and development to...

08:00
Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics), a private biopharmaceutical company specializing in oxygen therapeutics (previously known as "blood substitutes") for both human and veterinary use, today announced   the signing of an $8.2...

08:00
Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover and develop drugs at scale, today announced a $1.6 million Phase 2 Small Business Innovation Research...

07:30
Palatin Technologies, Inc. , a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced Phase 1, first-in-human...

07:00
Opsens inc. ("Opsens" ou la "Société")  a annoncé aujourd'hui que son algorithme de pression diastolique appelé dPR, a été utilisé pour la première fois par le Dr Hitoshi Matsuo, cardiologue et président du Gifu Heart Centre au Japon....

07:00
Opsens Inc. ("Opsens")  announces that its Diastolic Pressure Ratio called dPR, has been used for the first time by Dr. Hitoshi Matsuo, cardiologist and President of the Gifu Heart Center Japan. The measurement of...

06:50
Evofem Biosciences, Inc., ("Evofem" or the "Company") today announced the last patient has completed her last visit in AMPOWER, the second Phase 3 clinical trial of Amphora® (L-lactic acid, citric acid and potassium bitartrate), its lead...

06:00
A distinguished panel of global authorities in myopia management gathered this week in Texas, on the eve of the American Academy of Optometry (AAOptom) Annual Meeting, seeking ways to help eye care professionals better assess and manage the growing...


7 novembre 2018

17:42
Une équipe de chercheurs du Dr Rath Research Institute en Californie a mis au point un vaccin contre le cancer efficace pour réduire la croissance tumorale. Ce vaccin à base de peptides cible des enzymes spécifiques appelées métalloprotéinases (MMP)...

16:20
Trovagene, Inc. , a clinical-stage oncology therapeutics company, using a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, today announced company...

16:15
VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the final five of 19 highly anticipated late-breaking clinical trial results at VIVA 18...

16:05
Ardelyx, Inc. , today reported business highlights and financial results for the third quarter ended September 30, 2018. "During our first Renal Day event, we heard strong feedback from physician, dietician and policy...

16:05
REGENXBIO Inc. , a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced financial results for the quarter ended...

16:01
DURECT Corporation today announced financial results for the three months ended September 30, 2018 and provided a corporate update.   Total revenues were $8.0 million and net loss was $2.7 million for the three months ended September 30, 2018 as...

16:00
DNAtrix, a leader in oncolytic virus immunotherapies for cancer, announced today that MD Anderson Cancer Center collaborator, Juan Fueyo, MD, will present preclinical results for DNX-2440, an armed oncolytic adenovirus that expresses OX40 ligand...

14:15
Phoenix Nest Inc. exclusively licensed a gene therapy for Sanfilippo syndrome (also known as Mucopolysaccharidosis IIIC, (MPSIIIC)) from The University of Manchester through its IP commercialization arm UMI3 Ltd. MPS IIIC is a devastating...

12:30
BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced the safety and efficacy data from the LUTONIX® Drug-Coated Balloon (DCB) IDE, level 1 clinical trial for a below-the-knee (BTK) indication....

12:19
VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces five more of the nineteen highly anticipated late-breaking clinical trial results at VIVA...

10:49
What would you say if you were told a preventative measure to being diagnosed with Alzheimer's disease or dementia is sitting in your kitchen pantry? According to Auburn University Harrison School of Pharmacy researcher Dr. Amal Kaddoumi, that could...

10:29
Glenmark Pharmaceuticals, a global pharmaceutical company, today announced the decision to launch a Phase 1 trial in solid tumors for its CD38xCD3 bispecific antibody GBR 1342. The decision is driven by recent findings derived from a...

09:10
BioMarin Pharmaceutical Inc. updated the investment community on the Company's research and development portfolio, which is focused on innovative therapies to treat rare and ultra-rare diseases. "BioMarin is poised to...

09:00
Mirati Therapeutics, Inc. , a clinical stage targeted oncology company, will present at the 27th Annual Credit Suisse Healthcare Conference in Scottsdale, Arizona on Wednesday, November 14th at 1:40 p.m. MST/ 12:40 p.m. PST. Charles M. Baum, M.D.,...

08:30
Ampio Pharmaceuticals, Inc. today is providing an update of the regulatory and clinical path activities required to file a Biologics License Application (BLA) for Ampiontm for the treatment of severe osteoarthritis-of-the-knee (OAK). Mr. Macaluso,...

08:15
Une équipe de chercheurs du Dr. Rath Research Institute en Californie a mis au point un vaccin anticancéreux efficace pour réduire la croissance tumorale. Ce vaccin à base de peptides cible des enzymes spécifiques appelées métalloprotéinases (MMP),...

08:00
A team of researchers from the Dr. Rath Research Institute in California has developed a cancer vaccine effective in reducing tumor growth. This peptide-based vaccine targets specific enzymes called metalloproteinases (MMPs) that are necessary for...

08:00
OncoSec Medical Incorporated (OncoSec) , a company developing intratumoral cancer immunotherapies, today announced that the first patient has been treated in KEYNOTE-890, a Phase 2 clinical trial for the treatment of late-stage triple negative breast...

07:30
Aridis Pharmaceuticals, Inc. , a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections, today announced that positive data...

07:30
Endo International plc announced positive results today from two identical Phase 3 RELEASE* studies of collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the buttocks. Subjects receiving CCH showed highly statistically...

07:00
Mirum Pharmaceuticals today announced that it has secured $120 million in Series A financing to support development of its lead drug candidate maralixibat for rare cholestatic liver diseases. The financing was led by New Enterprise Associates (NEA)...

03:18
Sosei Group Corporation ("Sosei" or "the Company") (TSE: 4565), announces that its wholly owned subsidiary Heptares Therapeutics has entered a new collaboration agreement designed to extend its leadership in GPCR medicine design and accelerate new...

03:00
CLEARWATER, Fla., Nov. 7, 2018 /PRNewswire-PRWeb/ -- Dr. Britten, an implant specialist and periodontist in Clearwater, Florida, says that sinus augmentation procedures are making it possible for many patients to have dental implants when years ago...

03:00
CartiHeal, developer of Agili-Ctm, a proprietary implant for the treatment of joint surface lesions, announced today the publication of a study demonstrating that the Agili-Ctm implant promotes the regenerative capacity of articular cartilage defects...

03:00
La société CartiHeal, qui a mis au point Agili-Ctm, implant exclusif servant au traitement des lésions de la surface articulaire, a annoncé aujourd'hui la publication d'une étude démontrant que l'implant Agili-Ctm favorisait la capacité de...

00:00
NORWOOD, Mass., Nov. 7, 2018 /PRNewswire-PRWeb/ -- Features such as 24/7 phone support, custom accommodations for special requests, and the flexibility to adjust to last-minute changes all contribute to client retention and referral business in the...


6 novembre 2018

16:53
VentureMed Group, Inc., a medical device company that develops and markets innovative interventional vascular solutions, announced the initiation of a new study to determine if the FLEX Dynamic Scoring Cathetertm reduces dissections and the need for...

16:23
Protagonist Therapeutics, Inc. today reported its financial results for the third quarter ended September 30, 2018, and provided a corporate update on its clinical development programs. "We are pleased to report...

16:15
VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the next four of 19 highly anticipated late-breaking clinical trial results at VIVA 18...

15:51
Today, the American College of Cardiology (ACC), American Heart Association (AHA), and Heart Rhythm Society (HRS) published guidelines on the diagnosis and treatment of bradycardia, an abnormally slow heart rate, along with the supporting systematic...

13:40
Years after his hand was amputated in a traumatic accident, a hand amputee can "feel" again, thanks to technology FIU engineers have developed. That person - the first person with a hand amputation who has been fitted with a neural-enabled prosthetic...

12:50
CartiHeal, developer of Agili-Ctm, a proprietary implant for the treatment of joint surface lesions, announced today the publication of a study demonstrating that the Agili-Ctm implant promotes the regenerative capacity of articular cartilage defects...

12:29
MiMedx Group, Inc. , a leading developer and marketer of regenerative and therapeutic biologics, today announced that five poster abstracts reporting on the Company's EpiFix® dehydrated Human Amnion/Chorion Membrane (dHACM) allograft and...

12:15
VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the first five of 19 highly anticipated late-breaking clinical trial results on Tuesday...

09:30
The Rainwater Charitable Foundation, one of the largest independent funders of neurodegenerative disease (ND) research, announced today that it is launching the Rainwater Prize Program to encourage and reward scientific progress toward new treatments...

09:19
Johnson & Johnson Vision today announced that data from two new studies on the visual effects of photochromic contact lenses will be presented at the 2018 American Academy of Optometry Annual Meeting in San Antonio (Academy 2018 San Antonio). Both...

09:12
The U.S. Food and Drug Administration (FDA), announced that the qualification of the Predictive Safety Testing Consortium (PSTC) Safety Biomarker Panel was approved for use in conjunction with standard of care methods to aid in the detection of...

08:38
BerGenBio ASA (OSE: BGBIO) announces that a Late-breaking Abstract detailing median progression-free-survival (mPFS) during the first stage of its phase II clinical trial with bemcentinib, a first-in-class selective oral AXL inhibitor, in combination...

2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20